Chest pain in the ambulance; prevalence, causes and outcome - a retrospective cohort study

Autor: Claus Kjær Pedersen, Carsten Stengaard, Kristian Friesgaard, Karen Kaae Dodt, Hanne Maare Søndergaard, Christian Juhl Terkelsen, Morten Thingemann Bøtker

Publikováno v: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 27, Iss 1, Pp 1-10 (2019)

Abstract Background Chest pain is common in acute ambulance transports. This study aims to characterize and compare ambulance-transported chest pain patients to non-chest pain patients and evaluate if patient characteristics and accompanying symptoms

Externí odkaz: https://doaj.org/article/7efb62335ada4f77b2c925ec9c5a9314

Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure

Autor: Nils Henrik Stubkjær Hansson, Jens Sörensen, Hendrik Johannes Harms, Won Yong Kim, Roni Nielsen, Lars P. Tolbod, Jørgen Frøkiær, Kirsten Bouchelouche, Karen Kaae Dodt, Inger Sihm, Steen Hvitfeldt Poulsen, Henrik Wiggers

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 2 (2017)

BackgroundMyocardial oxygen consumption (MVO2) and its coupling to contractile work are fundamentals of cardiac function and may be involved causally in the transition from compensated left ventricular hypertrophy to failure. Nevertheless, these proc

Externí odkaz: https://doaj.org/article/89adc81385ea47e4a6605ccaf372ec5e

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 x 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (met-HeFT)☆

Autor: Kiomars Mahboubi, Jens Brønnum-Schou, Jacob E. Møller, Jawdat Abdulla, Christian Torp-Petersen, Henrik Wiggers, Gitte Nielsen, Anders Hostrup Larsen, Karen Kaae Dodt, Anne Sejr Knudsen, Søren Lund Kristensen, Jens Lomholdt, Christian Hassager, Helene Nørrelund, Dan Eik Høfsten, Vibeke Brogaard Hansen, Søren Vraa, Hans Eiskjær, Søren Mellemkjær, Lars Køber, Malene Hollingdal, Ilan Raymond, O.W. Nielsen, Kristine Serup-Hansen, Jens Christian Refsgaard, Kirsten Vilain Mikkelsen, Anders Barasa, Niels Eske Bruun, Hans Erik Bøtker, Bo Martin Bibby, Finn Gustafsson, Morten Schou, Morten Bøttcher, Gunnar Gislason, Bartlomiej Jonczy, Jette Sandberg Madsen, Flemming Hald Steffensen, Monica Petronela Poenaru, Karen Sillesen, Mikael Kjær Poulsen

Publikováno v: American Heart Journal
Wiggers, H, Køber, L, Gislason, G, Schou, M, Poulsen, M K, Vraa, S, Nielsen, O W, Bruun, N E, Nørrelund, H, Hollingdal, M, Barasa, A, Bøttcher, M, Dodt, K, Hansen, V B, Nielsen, G, Knudsen, A S, Lomholdt, J, Mikkelsen, K V, Jonczy, B, Brønnum-Schou, J, Poenaru, M P, Abdulla, J, Raymond, I, Mahboubi, K, Sillesen, K, Serup-Hansen, K, Madsen, J S, Kristensen, S L, Larsen, A H, Bøtker, H E, Torp-Petersen, C, Eiskjær, H, Møller, J, Hassager, C, Steffensen, F H, Bibby, B M, Refsgaard, J, Høfsten, D E, Mellemkjær, S & Gustafsson, F 2021, ' The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART) : A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT) ', American Heart Journal, vol. 231, pp. 137-146 . https://doi.org/10.1016/j.ahj.2020.09.020
Wiggers, H, Køber, L, Gislason, G, Schou, M, Poulsen, M K, Vraa, S, Nielsen, O W, Bruun, N E, Nørrelund, H, Hollingdal, M, Barasa, A, Bøttcher, M, Dodt, K, Hansen, V B, Nielsen, G, Knudsen, A S, Lomholdt, J, Mikkelsen, K V, Jonczy, B, Brønnum-Schou, J, Poenaru, M P, Abdulla, J, Raymond, I, Mahboubi, K, Sillesen, K, Serup-Hansen, K, Madsen, J S, Kristensen, S L, Larsen, A H, Bøtker, H E, Torp-Petersen, C, Eiskjær, H, Møller, J, Hassager, C, Steffensen, F H, Bibby, B M, Refsgaard, J, Høfsten, D E, Mellemkjær, S & Gustafsson, F 2021, ' The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART) : A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT) ', American Heart Journal, vol. 231, pp. 137-146 . https://doi.org/10.1016/j.ahj.2020.09.020, https://doi.org/10.1016/j.ahj.2020.09.020

OBJECTIVES: The DANHEART trial is a multicenter, randomized (1:1), parallel-group, double-blind, placebo-controlled study in chronic heart failure patients with reduced ejection fraction (HFrEF). This investigator driven study will include 1500 HFrEF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1e160357c3400540d64d48cbe0cd8c
http://europepmc.org/articles/PMC7544566

A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction – the AROMI trial

Autor: Hanne Maare Søndergaard, Karen Kaae Dodt, Jakob Hjort, Christian Juhl Terkelsen, Carsten Stengaard, Claus Kjær Pedersen, Morten Thingemann Bøtker

Publikováno v: Trials
Trials, Vol 19, Iss 1, Pp 1-14 (2018)
Pedersen, C K, Stengaard, C, Søndergaard, H, Dodt, K K, Hjort, J, Bøtker, M T & Terkelsen, C J 2018, ' A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction-the AROMI trial ', Current Controlled Trials in Cardiovascular Medicine
, vol. 19, no. 1, pp. 683 . https://doi.org/10.1186/s13063-018-2990-z

Background Suspicion of acute myocardial infarction (AMI) is among the most common reasons for admission to hospital in Denmark. Owing to this suspicion, an estimated 50,000 patients are admitted every year. Only 15–20% are finally diagnosed with A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df313a1ec89d59340de221a1b77a7d54
http://europepmc.org/articles/PMC6291993

Metoprolol Reduces Hemodynamic and Metabolic Overload in Asymptomatic Aortic Valve Stenosis Patients: A Randomized Trial

Autor: Nils Henrik Hansson, Jørgen Frøkiær, Lars Poulsen Tolbod, Henrik Wiggers, Hendrik J. Harms, Jens Sörensen, Karen Kaae Dodt, Inger Sihm, Kirsten Bouchelouche, Won Yong Kim, Roni Nielsen, Steen Hvitfeldt Poulsen

Publikováno v: Hansson, N H, Sörensen, J, Harms, H J, Kim, W Y, Nielsen, R, Tolbod, L P, Frøkiær, J, Bouchelouche, K, Dodt, K K, Sihm, I, Poulsen, S H & Wiggers, H 2017, ' Metoprolol Reduces Hemodynamic and Metabolic Overload in Asymptomatic Aortic Valve Stenosis Patients : A Randomized Trial ', Circulation. Cardiovascular Imaging (Online), vol. 10, no. 10 . https://doi.org/10.1161/CIRCIMAGING.117.006557

Background— Currently, no pharmacological treatment can modify the natural history of aortic valve stenosis (AS). This underlines the critical need to explore novel treatment strategies, which could postpone or prevent the need for aortic valve rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a13a86edd3027a78488f4e589607746
https://pubmed.ncbi.nlm.nih.gov/28956777